|
|
 |
|
Viewing report
|
|
|
|
Sonus Pharmaceuticals Inc: Premium Company Profile
Datamonitor, Jan 2008, Pages: 41
Sonus Pharmaceuticalss main focus is to discover, develop and commercialize products for the treatment of diseases in the therapeutic area of oncology. The company seeks to build a franchise of oncology products through its own internal efforts.
Scope
- Contains corporate strategy, value chain presence and SWOT Analysis
- Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
- Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights of this title
Sonus Pharmaceuticals is focused on the discovery, development and commercialization of pharmaceutical products for oncology indications. The company has only one program in its pipeline, namely, TOCOSOL Camptothecin, for the treatment of solid tumors.
Sonus derives its revenues from collaboration and licensing agreements. These revenues are related to the collaboration agreement with Bayer Schering, under which Bayer Schering was granted worldwide exclusive license to market and promote TOCOSOL Paclitaxel and was responsible for clinical development and regulatory activities outside of the US.
Sonus aims to apply its focus on advancing its second oncology product candidate, TOCOSOL Camptothecin, which was moved into a Phase I clinical trial in September 2006. In addition, it intends to identify and acquire products/technologies that are complementary to its focus in oncology in order to broaden the business and market opportunities.
Key reasons to purchase this title
- Access all the important information and analysis on the company in a single report
- Understand companys strengths, weaknesses, opportunities and threats along with business strategy and value chain
- Gain access to companys adjusted five year financial data along with key ratios and market capitalization
Customers who bought this item also bought
QLT Inc: Premium Company Profile
Imaging Agents - Global Strategic Business Report
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
The Pharma R&D Fact Book 2007
Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth
United States Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
Multiple Sclerosis Therapeutics - Global Strategic Business Report
Animal Pharms Top Tier Companies: 2007 Edition
Martek Biosciences Corp: Premium Company Profile
Top 10 Healthcare Trends in 2011
|
|
|
|
